Christopher David Oreilly
Global Head of Investor Relations at Takeda
Based in Japan
7-day free trial · no credit card
Seniority
C-Team
Department
General Business & Management
Location
Japan
Industry
Pharmaceutical Manufacturing
Company size
37K
Contact information
Reveal Christopher's email and phone
Direct contact data is gated. Sign up and reveal. You only pay for verified records.
c•••••••@takeda.com
Phone
5 credits+81 ••• •••• ••••
You only pay for valid records. Bounced emails and disconnected numbers cost nothing.
Background
About Christopher David Oreilly
2024 Institutional Investor Survey All-Japan Executive Team Ranked #1 "Best IR Professional"; Ranked #1 "Best IR Program" in Biotechnology & Pharmaceuticals Overall rankings 2023 Institutional Investor Survey All-Japan Executive Team: Ranked #1 "Best IR Professional" in Biotechnology & Pharmaceuticals Sell-Side rankings 2021 Institutional Investor Survey All-Japan Executive Team: Ranked #1 "Best IR Professional" in Biotechnology & Pharmaceuticals sector Overall rankings. 2018, 2019, 2020 Institutional Investor Survey All-Japan Executive Team: Ranked within top 3 "Best IR Professional" in Biotechnology & Pharmaceuticals Buy-Side rankings.
Decision-makers
Other people at Takeda
- HSStaff
Himshikha Sharma
Patient Services Specialist · Healthcare & Human Services
- KRDirector
Karina Recio
Sr Director Global Head of G & a Finance, Digital and Fp & a Excellence - Corporate Planning · Finance & Accounting
- ATStaff
Alexander Tedeschi
Senior Research Associate · Research & Development
- DUStaff
Dietmar Uschan
Reliability Engineer · Engineering
- JKOther
Jennifer Kelly
Rare Disease Regional Business Manager, Hereditary Angioedema · Other
Build a list of verified contacts at Takeda
Free for 7 days · 50 credits · no card · only pay for verified records.
Reach more buyers like Christopher
250M+ professionals with verified email and phone. You only pay for records that actually verify.
7-day trial · no credit card · cancel anytime